Thomas Niel

Thomas Niel

Expertise: Micro-Cap Stocks, Shareholder Activist Stocks, Value Stocks

Education: Bachelors in Accounting, CFA Program Participant (Completed Level I in 2017)

About Thomas:
Thomas Niel is an investment writer at InvestorPlace. With a professional background in accounting and financial analysis, his understanding of both words and figures pays dividends when writing clear, concise stock analysis.

A value investor at heart, Thomas looks at the fundamentals. Peer analysis and earnings multiples rarely tell the whole story. But, Thomas believes valuation metrics are a great starting point to separate the wheat from the chaff.

His work has appeared at several websites, including Seeking Alpha and TipRanks. Outside of investment research, Thomas provides inbound marketing content to the investment management industry.

You can follow Thomas on Twitter and check out his track record on TipRanks.

Recent Articles

It’s Still Not The Time to Buy Quantumscape Stock

Sitting tight, and waiting for another wave of weakness to buy, remains your best move with QS stock.

Other Cryptocurrencies Remain Better Buys Than Ripple

Investors bullish on crypto have better options than Ripple among the many major established coins and altcoins

How Long The Shiba Inu Rally Lasts is Anyone’s Guess

Still a gamble, even as it tries to become more than a speculative "memecoin," Shiba Inu remains the ultimate "all bets are off" situation.

7 Penny Stocks to Buy – While They’re Still Penny Stocks

So, which penny stocks should you buy, with the potential to break through the ceiling, en route to higher prices? Consider these seven top names that could do just that: Cinedigm (NASDAQ:CIDM) Vaalco Energy (NYSE:EGY) Globalstar (NYSEAMERICAN:GSAT) Mind Medicine (NASDAQ:MNMD) Romeo Power (NYSE:RMO) Senseonics (NYSEAMERICAN:SENS) Uranium Energy (NYSEAMERICAN:UEC)

This Ocugen Stock Rally Makes Little Sense, But Watch Out Going Short

Highly volatile, with a tendency to make unwarranted moves higher, it's best to not go long (or short) OCGN stock.

Tilray Stock Is Still Poised to Turn Over a New Leaf

U.S. legalization, and Tilray's global expansion efforts could enable TLRY stock to climb significantly above its current levels.

Clover Health Stock Has an Outside Chance of Suprising in Its Upcoing Earnings

If you strongly believe the company's heavy losses are transitory? By all means, roll the dice with CLOV stock. But if you think it'll still have cost control issues? Or, that other risks will continue to weigh down on it? Holding off for now may be the way to go.

After Falling Below $10, It’s ‘Game On’ for New Positions in Skillz Stock

No longer on the path to becoming a busted growth story, SKLZ stock could start to bounce back. Ahead of a recovery, now may be the time to buy.

7 Ways to Profit From Sports Gambling Without Placing a Bet

Grab yourself a piece of the action with these seven sports gambling stocks, all without having to worry about covering the spread!

Don’t Bet Your Bottom Dollar on Ethereum, But Consider It a Buy

The path to higher prices remains clear for Ethereum. Thanks both to increased usage, and increased institutional inflows. This points to buying it on any pullback. Just don't go hog wild, and put too much of your portfolio into it and other cryptos. Despite the market's shrugging off of it as a threat, regulation could still dampen its appeal.